HIT
Health In Tech, Inc.
NasdaqCMUSDEQUITY
Technology
DELAYED
Last price
0.99
▼ 0.03 (2.94%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.99
Prev close
1.02
Day high
1.03
Day low
0.96
Volume
66.69K
Market cap
$65.53M
P/E (TTM)
—
52W range
0.85 – 4.02
Day trading desk
Gap from prior close
-2.94%
Prior close 1.02
VWAP
1.01
-2.36% from price
Relative volume
0.52×
Quiet session
Session range
7.29%
0.96 – 1.03
Position in range
43%
Mid range
ATR (14D)
0.07
6.60% of price
Prior day high
1.02
PDH
Prior day low
0.99
PDL
Bid / ask spread
—
Quote not published
Session volume
64.03K
Avg 123.10K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.50%
+0.9%
1M
-5.66%
-9.4%
3M
+8.34%
+5.2%
6M
-15.97%
-27.0%
YTD
-37.11%
-49.4%
1Y
-68.85%
-88.8%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HIT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
40.51M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 8, 26 | SHRESTHA SANJAY K Director |
STOCK | 18.87K | $20.00K | Direct |
| Jul 8, 26 | HOWARD WILLIAM D. Director |
STOCK | 18.87K | $20.00K | Direct |
| Jul 8, 26 | HAYES TIMOTHY Director |
STOCK | 18.87K | $20.00K | Direct |
| May 20, 26 | LOCKETT JONATHAN DEL Officer |
STOCK | 50.00K | $0 | Direct |
| Apr 10, 26 | MCSTRAVOCK JOHN General Counsel |
STOCK | 5.00K | $0 | Direct |
| Apr 8, 26 | SHRESTHA SANJAY K Director |
STOCK | 13.60K | $18.49K | Direct |
| Apr 8, 26 | HOWARD WILLIAM D. Director |
STOCK | 13.60K | $18.49K | Direct |
| Apr 8, 26 | HAYES TIMOTHY Director |
STOCK | 13.60K | $18.49K | Direct |
| Jan 6, 26 | JOHNSON TIM DONALD Chief Executive Officer |
STOCK | 1.00M | $0 | Direct |
| Jan 6, 26 | QIAN LINLIN Chief Financial Officer |
STOCK | 1.00M | $0 | Direct |
| Jan 6, 26 | HASAN ZAIN SYED Officer |
STOCK | 200.00K | $0 | Direct |
| Nov 5, 25 | CLARKSON MICHAEL DAVID Chief Technology Officer |
STOCK | 8.00K | $0 | Direct |
| Oct 8, 25 | SHRESTHA SANJAY K Director |
STOCK | 5.73K | $20.00K | Direct |
| Oct 8, 25 | HOWARD WILLIAM D. Director |
STOCK | 5.73K | $20.00K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
HASAN ZAIN SYED |
Officer | 220.00K | Stock Award(Grant) |
HAYES TIMOTHY |
Director | 138.51K | Stock Award(Grant) |
HOWARD WILLIAM D. |
Director | 138.51K | Stock Award(Grant) |
JOHNSON TIM DONALD |
Chief Executive Officer | 23.55M | Stock Award(Grant) |
LOCKETT JONATHAN DEL |
Officer | 143.54K | Stock Award(Grant) |
PLANTHOLT DUSTIN |
Officer | 64.00K | Stock Award(Grant) |
QIAN LINLIN |
Chief Financial Officer | 9.13M | Stock Award(Grant) |
SHRESTHA SANJAY K |
Director | 101.20K | Stock Award(Grant) |
UMEMEZIA CHIKE |
Director | 128.47K | Stock Award(Grant) |
YOUSUF IMRAN MOHAMMED |
Chief Technology Officer | 107.00K | Stock Award(Grant) |
Fundamentals
Market cap$65.53M
Enterprise value$59.20M
Revenue (TTM)$32.83M
Gross profit$17.70M
EBITDA—
Net income$-3.95M
EPS (TTM)$-0.07
Free cash flow$-6.67M
Total cash$6.51M
Total debt$102.94K
Book value / share$0.30
Shares outstanding53.83M
Float20.30M
Short % of float3.50%
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E25.00
PEG ratio—
Price / sales—
Price / book3.36
EV / revenue1.80
EV / EBITDA—
Gross margin53.93%
Operating margin-42.68%
Profit margin-12.03%
Return on equity-21.91%
Return on assets-12.72%
Debt / equity0.53
Current ratio2.18
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $33.33M | $19.49M | $19.15M | $5.77M | +71.0% |
| Operating revenue | $33.33M | $19.49M | $19.15M | $5.77M | +71.0% |
| Cost of revenue | $12.39M | $4.05M | $2.30M | $334.19K | +205.8% |
| Gross profit | $20.94M | $15.44M | $16.85M | $5.44M | +35.6% |
| Research & development | $1.57M | $2.81M | $2.00M | $794.62K | -44.2% |
| Selling, general & admin | $17.84M | $11.64M | $11.46M | $4.44M | +53.3% |
| Total operating expense | $19.41M | $14.45M | $13.46M | $5.23M | +34.3% |
| Operating income | $1.53M | $989.90K | $3.38M | $205.58K | +54.4% |
| Net interest income | $409.92K | -$372.12K | $38.80K | -$4.57K | +210.2% |
| Pre-tax income | $1.67M | $889.00K | $3.42M | $201.01K | +88.3% |
| Tax provision | $395.33K | $218.52K | $945.24K | $121.27K | +80.9% |
| Net income | $1.28M | $670.48K | $2.48M | $79.74K | +90.7% |
| Net income to common | $1.28M | $670.48K | $2.48M | $79.74K | +90.7% |
| Basic EPS | 0.02 | 0.01 | 0.05 | 0.00 | +62.9% |
| Diluted EPS | 0.02 | 0.01 | 0.05 | 0.00 | +62.9% |
| EBIT | $1.67M | $1.38M | $3.42M | $205.58K | +21.0% |
| EBITDA | $2.57M | $1.93M | $3.76M | $205.58K | +33.7% |
| Basic shares | 55.84M | 54.61M | 54.07M | 54.07M | +2.3% |
| Diluted shares | 57.74M | 54.61M | 54.07M | 54.07M | +5.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.67M | $7.85M | $2.42M | $1.49M | -2.3% |
| Cash & short-term investments | $7.67M | $7.85M | $2.42M | $1.49M | -2.3% |
| Accounts receivable | $756.29K | $1.65M | $2.24M | $956.34K | -54.1% |
| Total current assets | $16.16M | $10.78M | $6.86M | $25.43M | +49.9% |
| Property, plant & equipment | $139.94K | $206.27K | $266.64K | $321.81K | -32.2% |
| Goodwill & intangibles | $6.53M | $3.96M | $3.56M | $2.76M | +64.8% |
| Total assets | $23.09M | $15.77M | $11.50M | $28.56M | +46.4% |
| Total current liabilities | $5.16M | $2.13M | $4.78M | $24.02M | +142.0% |
| Current debt | — | — | $1.65M | — | — |
| Total debt | $139.81K | $206.69K | $1.92M | $316.09K | -32.4% |
| Total liabilities | $5.98M | $2.60M | $5.41M | $27.14M | +130.0% |
| Retained earnings | $5.22M | $3.94M | $3.27M | $794.26K | +32.4% |
| Shareholder equity | $17.11M | $13.17M | $6.09M | $1.05M | +29.9% |
| Working capital | $11.00M | $8.65M | $2.08M | $1.41M | +27.2% |
| Net tangible assets | $10.58M | $9.21M | $2.53M | -$1.71M | +14.9% |
| Shares issued | 57.71M | 54.61M | 54.07M | 54.07M | +5.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.28M | $670.48K | $3.96M | -$243.34K | +90.7% |
| Depreciation & amortisation | $900.58K | $541.14K | $339.30K | $0 | +66.4% |
| Stock-based compensation | $1.57M | $468.49K | $0 | $566.04K | +235.2% |
| Change in working capital | -$5.23M | $156.52K | -$2.89M | $451.06K | -3,443.9% |
| Operating cash flow | $3.13M | $2.18M | $1.53M | $782.75K | +44.0% |
| Capital expenditure | -$3.19M | -$900.75K | -$1.14M | -$1.22M | -254.1% |
| Investing cash flow | -$3.13M | -$836.75K | -$1.94M | -$1.22M | -273.6% |
| Financing cash flow | -$187.39K | $4.09M | $1.34M | $1.88M | -104.6% |
| Free cash flow | -$56.11K | $1.28M | $384.52K | -$436.63K | -104.4% |
| End cash position | $7.67M | $7.85M | $2.42M | $1.49M | -2.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $8.77M | $7.51M | $8.49M | $9.31M | $8.01M | +16.8% |
| Operating revenue | $8.77M | $7.51M | $8.49M | $9.31M | $8.01M | +16.8% |
| Cost of revenue | $4.26M | $3.38M | $3.35M | $3.00M | $2.66M | +26.1% |
| Gross profit | $4.51M | $4.13M | $5.14M | $6.31M | $5.36M | +9.2% |
| Research & development | $920.39K | $213.11K | $235.82K | $582.61K | $537.72K | +331.9% |
| Selling, general & admin | $5.75M | $4.09M | $4.41M | $5.00M | $4.34M | +40.6% |
| Total operating expense | $6.67M | $4.30M | $4.65M | $5.58M | $4.87M | +55.1% |
| Operating income | -$2.16M | -$170.81K | $493.52K | $725.07K | $480.66K | -1,163.5% |
| Net interest income | $67.47K | $104.66K | $111.70K | $108.20K | $85.37K | -35.5% |
| Pre-tax income | -$2.07M | -$443.74K | $600.22K | $833.27K | $684.42K | -366.1% |
| Tax provision | -$480.07K | -$141.18K | $148.05K | $202.64K | $185.83K | -240.0% |
| Net income | -$1.59M | -$302.56K | $452.18K | $630.63K | $498.59K | -425.0% |
| Net income to common | -$1.59M | -$302.56K | $452.18K | $630.63K | $498.59K | -425.0% |
| Basic EPS | -0.03 | -0.01 | 0.01 | 0.01 | 0.01 | -200.0% |
| Diluted EPS | -0.03 | -0.01 | 0.01 | 0.01 | 0.01 | -200.0% |
| EBIT | -$2.16M | -$443.74K | $600.22K | $833.27K | $480.66K | -386.4% |
| EBITDA | -$1.75M | -$33.11K | $818.20K | $969.25K | $616.64K | -5,199.4% |
| Basic shares | 57.35M | 56.91M | 56.43M | 55.38M | 54.62M | +0.8% |
| Diluted shares | 57.35M | 58.64M | 58.77M | 55.63M | 57.00M | -2.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | +34.6% |
| Cash & short-term investments | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | +34.6% |
| Accounts receivable | $3.74M | $756.29K | $868.63K | $1.28M | $2.11M | +394.2% |
| Total current assets | $22.09M | $16.16M | $15.05M | $14.85M | $15.57M | +36.7% |
| Property, plant & equipment | $122.33K | $139.94K | $157.12K | $173.90K | $190.28K | -12.6% |
| Goodwill & intangibles | $6.71M | $6.53M | $6.18M | $5.52M | $4.74M | +2.7% |
| Total assets | $28.97M | $23.09M | $22.76M | $22.18M | $21.33M | +25.4% |
| Total current liabilities | $7.05M | $5.16M | $5.24M | $5.39M | $6.75M | +36.7% |
| Total debt | $121.59K | $139.81K | $157.60K | $174.36K | $190.72K | -13.0% |
| Total liabilities | $7.36M | $5.98M | $5.60M | $5.75M | $7.17M | +23.2% |
| Retained earnings | $3.63M | $5.22M | $5.52M | $5.07M | $4.44M | -30.4% |
| Shareholder equity | $21.60M | $17.11M | $17.16M | $16.42M | $14.16M | +26.2% |
| Working capital | $15.04M | $11.00M | $9.81M | $9.46M | $8.82M | +36.7% |
| Net tangible assets | $14.89M | $10.58M | $10.98M | $10.90M | $9.42M | +40.8% |
| Shares issued | 65.56M | 57.71M | 56.49M | 56.38M | 54.67M | +13.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.59M | -$302.56K | $452.18K | $630.63K | $498.59K | -425.0% |
| Depreciation & amortisation | $403.47K | $410.63K | $217.98K | $135.98K | $135.98K | -1.7% |
| Stock-based compensation | $366.56K | $76.73K | $292.55K | $707.96K | $493.17K | +377.7% |
| Change in working capital | -$2.11M | -$2.08M | -$1.69M | -$126.92K | -$1.33M | -1.3% |
| Operating cash flow | -$3.32M | $451.21K | $673.97K | $1.48M | $527.35K | -835.6% |
| Capital expenditure | -$362.13K | -$831.71K | -$744.84K | -$909.90K | -$703.48K | +56.5% |
| Investing cash flow | -$362.13K | -$767.71K | -$744.84K | -$909.90K | -$703.48K | +52.8% |
| Financing cash flow | $6.34M | -$37.36K | -$43.69K | -$8.25K | -$98.09K | +17,060.6% |
| Free cash flow | -$3.68M | -$380.50K | -$70.87K | $571.38K | -$176.12K | -867.5% |
| End cash position | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | +34.6% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.03 | -0.03 | -14.7% |
| Mar 2026 | -0.02 | -0.03 | -50.0% |
| Dec 2025 | -0.01 | -0.01 | 0.0% |
| Sep 2025 | 0.01 | 0.01 | 0.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.04 | 1 | $11.52M | +35.7% |
| Next quarter | -0.03 | 1 | $15.37M | +104.7% |
| Current year | -0.10 | 1 | $43.47M | +30.4% |
| Next year | 0.04 | 2 | $71.23M | +63.9% |
Analyst targets & ownership
Mean target$3.70
High target$4.10
Low target$3.00
Implied upside273.74%
Analyst count3
ConsensusSTRONG BUY
Strong buy / Buy1 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders61.82%
Held by institutions8.78%
Institutions holding25
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.03
-4.02% from price
SMA 20
1.07
-6.48% from price
SMA 50
1.06
-5.57% from price
SMA 100
1.18
-16.10% from price
SMA 200
1.35
-25.72% from price
EMA 12
1.04
-4.65% from price
EMA 26
1.06
-6.41% from price
EMA 50
1.09
-8.81% from price
RSI (14)
41.3
Neutral
MACD (12,26,9)
-0.02
Hist -0.01
ATR (14)
0.07
6.54% of price
Realised vol 30D
49.0%
Annualised
Bollinger upper
1.17
20, 2σ
Bollinger lower
0.97
20, 2σ
50 / 200 cross
Death
1.06 vs 1.35
Trend bias
Below 200
-25.72%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.18
More volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
49.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-77.0%
Peak to trough
Max drawdown 5Y
-92.6%
Peak to trough
ATR 14
0.07
6.54% of price
Beta (reported)
—
5Y monthly, from filing
Short interest
Shares short
713.96K
Prior 565.39K
Change vs prior
+26.3%
Shorts adding
% of float
3.50%
Normal
% of shares out
1.09%
Against total outstanding
Days to cover
12.1
Crowded exit
Float
20.30M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 26 | Maxim Group | MAINTAINED | Buy | Buy |
| Apr 20, 26 | Craig-Hallum | INITIATED | — | Buy |
| Jun 26, 25 | Maxim Group | INITIATED | — | Buy |
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-13
Offering Registrations
S-3/A · 2026-06-26
Offering Registrations
S-3 · 2026-06-10
Offering Registrations
S-3/A · 2026-05-22
Corporate Changes & Voting Matters
8-K · 2026-05-14
Corporate Changes & Voting Matters
8-K · 2026-05-13
Corporate Changes & Voting Matters
8-K · 2026-05-01
Offering Registrations
S-3 · 2026-04-24
Headlines
Health In Tech (HIT) Q2 2026 Earnings Call Transcript
Motley Fool · 2d ago
Health In Tech, Inc. Q2 2026 Earnings Call Summary
Moby · 9d ago
Health In Tech Inc (HIT) (Q2 2026) Earnings Call Highlights: Strategic Carrier Shift and Hitrix ...
GuruFocus.com · 9d ago
Health In Tech Q2 Earnings Call Highlights
MarketBeat · 9d ago
Health In Tech Reports Second Quarter 2026 Financial Results
PR Newswire · 9d ago
Health In Tech Inc (HIT) Q2 2026 Earnings Report Preview: What To Expect
GuruFocus.com · 11d ago
/C O R R E C T I O N -- Health In Tech, Inc./
PR Newswire · 19d ago
Health In Tech Added to Russell Microcap Index
MT Newswires · 55d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.